S
MURA

SignatureFD’s Mural Oncology MURA Stock Holding History

SignatureFD’s Portfolio MURA Stock Details MURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,500
Closed -$3.15K – 3367
2025
Q1 		$3.15K Hold
2,500
– – ﹤0.01% 2747
2024
Q4 		$8.05K Buy
2,500
+2,499
+249,900% +$8.81K ﹤0.01% 2447
2024
Q3 		$3 Hold
1
– – ﹤0.01% 3232
2024
Q2 		$3 Hold
1
– – ﹤0.01% 3112
2024
Q1 		$5 Sell
1
-74
-99% -$359 ﹤0.01% 3158
2023
Q4 		$444 Buy
+75
New +$302 ﹤0.01% 2988

Other funds holding MURA

SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SignatureFD's MURA Position: Q2 2025 in Review

SignatureFD sold out of Mural Oncology (MURA) in Q2 2025, closing a stake of 2,500 shares — an estimated $3.15K sold.

SignatureFD first reported a position in MURA in Q4 2023 and held it in 6 quarters. The position peaked at $8.05K in Q4 2024. 66 funds tracked by Wall St. Rank hold MURA as of Q2 2025.

  • SignatureFD reported no remaining Mural Oncology position as of Q2 2025 after selling out during the quarter.
  • SignatureFD sold 2,500 Mural Oncology shares in Q2 2025, an estimated $3.15K.
  • SignatureFD first reported a position in Mural Oncology in Q4 2023 and held it in 6 quarters.
  • SignatureFD's Mural Oncology position peaked at $8.05K in Q4 2024.
  • 66 funds tracked by Wall St. Rank held Mural Oncology as of Q2 2025.

Based on SignatureFD's 13F filing for Q2 2025, filed 16 Jul 2025.